首页> 外国专利> Health related quality of life and health-related temporary improvement beneficial patterns drug ingredients used in prostate cancer patients' health-related quality of life

Health related quality of life and health-related temporary improvement beneficial patterns drug ingredients used in prostate cancer patients' health-related quality of life

机译:与健康有关的生活质量和与健康有关的暂时改善有益模式前列腺癌患者与健康有关的生活质量中使用的药物成分

摘要

It REFERS TO A composition comprising an antagonist of endothelin receptor AS A pyrrolidine compound of formula Ia, wherein R1 and R2 are alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, substituted cycloalkyl, halo, aryl, heteroaryl , HETEROCICLO, OH, O-ALKYL; R3 IS R4SO2R5, R4COR5; R4 IS ALKYL, (CH2) -ALKENYL, (CH2) ALKYNYL, NR6R7, AMONG OTHERS, R5 IS LINK, ALKYLENE, NH-ALKYLENE, N-ALKYL-ALKYLENE; R6 AND R7 ARE H, ALKYL, (CH2) -ALKYLENE, (CH2) -ALKYNYLL, CYCLOALKYL, ARYL, AMONG OTHERS; USING FROM 1mg / DAY TO 25mg / DAY;Comment more than a month ago - (1 -) (1 - (1 -) (1 -) (1 - (1-benzodiazepine-5-il-1 - ((n)) N-distributlamin (carbonil) (methyl) pirrolidin-3-carboxilico, etc. Composition may be useful in the treatment of prostate cancer
机译:涉及包含内皮素受体拮抗剂AS的式Ia的吡咯烷化合物的组合物,其中R 1和R 2是烷基,烯基,炔基,环烷基,芳基,杂芳基,取代的环烷基,卤素,芳基,杂芳基,HETEROCICLO,OH,O -烷基; R3是R4SO2R5,R4COR5; R4是烷基,(CH2)-亚烷基,(CH2)炔基,NR6R7,在其他基团中,R5是连接的,烷基,NH-烷基,N-烷基-烷基; R6和R7是H,烷基,(CH2)-亚烷基,(CH2)-烷基,环烷基,芳基等。从每天1毫克到每天25毫克使用;一个多月前发表评论-(1--(1--(1--)(1--)(1--(1-苯并二氮杂-5-il-1-((n)) )N-分布纤溶素(碳)(甲基)吡咯烷酮-3-羧苄酯等。该组合物可用于治疗前列腺癌

著录项

  • 公开/公告号PE20021032A1

    专利类型

  • 公开/公告日2002-11-12

    原文格式PDF

  • 申请/专利权人 ABBOTT LABORATORIES;

    申请/专利号PE20050200200

  • 申请日2002-04-11

  • 分类号A61K31/4025;A61P13/08;

  • 国家 PE

  • 入库时间 2022-08-22 00:01:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号